Otto Bock launches wireless implant for stroke disability in UK
This article was originally published in Clinica
Executive Summary
Otto Bock has launched its ActiGait system in the UK. The wireless nerve-stimulating implant is designed to treat patients with drop foot, a common consequence of stroke or other damage to the central nervous system. Patients with the condition, which is characterised by abnormal gait, are unable to raise their foot because of weakness in or paralysis of the dorsiflexor muscles. ActiGait is implanted beneath the skin of the thigh and controlled by a unit that is worn on a belt. Stimulation activates the muscles of the front and lower leg, leading to dorsiflexion and a steadier and more natural walking pattern, Duderstadt, Germany-based Otto Bock says.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.